Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytarabine | 1 | 2023 | 8 | 0.920 |
Why?
|
| Leukemia | 1 | 2023 | 56 | 0.890 |
Why?
|
| Liver Abscess, Amebic | 1 | 2017 | 1 | 0.610 |
Why?
|
| Entamoeba | 1 | 2017 | 3 | 0.610 |
Why?
|
| Entamoebiasis | 1 | 2017 | 2 | 0.610 |
Why?
|
| Entamoeba histolytica | 1 | 2017 | 4 | 0.610 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2016 | 12 | 0.570 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 30 | 0.570 |
Why?
|
| Neurites | 1 | 2016 | 39 | 0.570 |
Why?
|
| src-Family Kinases | 1 | 2016 | 46 | 0.560 |
Why?
|
| Cell Communication | 2 | 2016 | 97 | 0.550 |
Why?
|
| Astrocytes | 3 | 2016 | 255 | 0.550 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 182 | 0.530 |
Why?
|
| Phosphoproteins | 1 | 2016 | 163 | 0.520 |
Why?
|
| Brachyura | 4 | 2002 | 15 | 0.500 |
Why?
|
| Membrane Proteins | 4 | 2016 | 517 | 0.500 |
Why?
|
| Urodela | 5 | 2009 | 10 | 0.430 |
Why?
|
| Memory | 4 | 2002 | 170 | 0.420 |
Why?
|
| Erythrocytes | 5 | 2009 | 111 | 0.420 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2002 | 137 | 0.400 |
Why?
|
| Caveolin 1 | 5 | 2019 | 29 | 0.360 |
Why?
|
| Neurons | 2 | 2016 | 1175 | 0.350 |
Why?
|
| Octopamine | 1 | 2009 | 8 | 0.350 |
Why?
|
| Appetite | 1 | 2009 | 21 | 0.340 |
Why?
|
| Crustacea | 1 | 2009 | 22 | 0.340 |
Why?
|
| Avoidance Learning | 1 | 2009 | 62 | 0.330 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2013 | 73 | 0.290 |
Why?
|
| Gravitation | 1 | 2006 | 7 | 0.280 |
Why?
|
| Animals | 23 | 2017 | 15081 | 0.270 |
Why?
|
| Lymphocytes | 1 | 2006 | 118 | 0.260 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2002 | 99 | 0.260 |
Why?
|
| Protein Kinase C | 2 | 2013 | 120 | 0.210 |
Why?
|
| Aorta | 2 | 2013 | 167 | 0.210 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2013 | 130 | 0.210 |
Why?
|
| Potassium-Hydrogen Antiporters | 4 | 2009 | 4 | 0.210 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 234 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 133 | 0.200 |
Why?
|
| Organ Culture Techniques | 3 | 2017 | 103 | 0.190 |
Why?
|
| Potassium | 4 | 2009 | 112 | 0.180 |
Why?
|
| Astrocytoma | 1 | 2019 | 14 | 0.180 |
Why?
|
| Nicotinic Antagonists | 2 | 2012 | 30 | 0.180 |
Why?
|
| Cell Line | 1 | 2023 | 1354 | 0.170 |
Why?
|
| Sodium | 5 | 2009 | 103 | 0.170 |
Why?
|
| Cell Size | 2 | 2009 | 44 | 0.170 |
Why?
|
| Stress, Mechanical | 1 | 2019 | 113 | 0.170 |
Why?
|
| Neuroglia | 2 | 2011 | 124 | 0.170 |
Why?
|
| Receptors, Nicotinic | 2 | 2012 | 106 | 0.160 |
Why?
|
| Caveolins | 3 | 2007 | 8 | 0.160 |
Why?
|
| Cell Proliferation | 1 | 2023 | 1198 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2019 | 1908 | 0.150 |
Why?
|
| Rats | 7 | 2016 | 3483 | 0.150 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 42 | 0.150 |
Why?
|
| Cell Membrane | 4 | 2007 | 381 | 0.150 |
Why?
|
| Neuroprotective Agents | 2 | 2012 | 245 | 0.140 |
Why?
|
| Habituation, Psychophysiologic | 1 | 1996 | 17 | 0.140 |
Why?
|
| Virulence | 1 | 2017 | 223 | 0.140 |
Why?
|
| Ion Channel Gating | 2 | 2013 | 83 | 0.140 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1518 | 0.130 |
Why?
|
| Calcium Channels, L-Type | 2 | 2013 | 20 | 0.130 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 1994 | 1 | 0.130 |
Why?
|
| Antiporters | 1 | 1994 | 10 | 0.130 |
Why?
|
| Glutamic Acid | 2 | 2007 | 128 | 0.120 |
Why?
|
| Muscle Cells | 1 | 2013 | 11 | 0.120 |
Why?
|
| Anesthetics, Inhalation | 1 | 2013 | 3 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 602 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2013 | 75 | 0.110 |
Why?
|
| GABA Antagonists | 1 | 2012 | 29 | 0.110 |
Why?
|
| Humans | 9 | 2023 | 37093 | 0.110 |
Why?
|
| Prevalence | 1 | 2017 | 1455 | 0.110 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2013 | 86 | 0.110 |
Why?
|
| Glioma | 2 | 2005 | 79 | 0.100 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2009 | 46 | 0.100 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 95 | 0.100 |
Why?
|
| Amnesia | 2 | 2002 | 8 | 0.090 |
Why?
|
| Amphibian Proteins | 1 | 2009 | 3 | 0.090 |
Why?
|
| Male | 7 | 2017 | 20025 | 0.090 |
Why?
|
| Organelles | 2 | 1999 | 24 | 0.080 |
Why?
|
| Oxazoles | 1 | 2008 | 19 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2008 | 433 | 0.080 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2008 | 13 | 0.080 |
Why?
|
| Down-Regulation | 2 | 2007 | 435 | 0.080 |
Why?
|
| Time Factors | 3 | 2008 | 1742 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 502 | 0.070 |
Why?
|
| Cyclic AMP | 3 | 2013 | 131 | 0.070 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2007 | 61 | 0.070 |
Why?
|
| Adolescent | 1 | 2017 | 5363 | 0.070 |
Why?
|
| Aged | 2 | 2017 | 6741 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 237 | 0.070 |
Why?
|
| Ascaris | 1 | 1985 | 2 | 0.070 |
Why?
|
| N-Methylaspartate | 1 | 2005 | 57 | 0.070 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1985 | 79 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2007 | 290 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2008 | 308 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2013 | 364 | 0.060 |
Why?
|
| Synapses | 1 | 1985 | 180 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 10129 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2008 | 1039 | 0.060 |
Why?
|
| Cell Separation | 2 | 2013 | 93 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2002 | 21 | 0.050 |
Why?
|
| Escape Reaction | 1 | 2002 | 15 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2002 | 30 | 0.050 |
Why?
|
| Dizocilpine Maleate | 1 | 2002 | 48 | 0.050 |
Why?
|
| Plant Extracts | 1 | 2005 | 286 | 0.050 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 143 | 0.050 |
Why?
|
| Photic Stimulation | 1 | 2002 | 115 | 0.050 |
Why?
|
| Adult | 2 | 2017 | 11712 | 0.050 |
Why?
|
| Barium | 2 | 2013 | 17 | 0.050 |
Why?
|
| Potassium Channel Blockers | 2 | 2013 | 33 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2002 | 314 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2019 | 30 | 0.040 |
Why?
|
| Phosphorylation | 3 | 2009 | 928 | 0.040 |
Why?
|
| Protein Kinases | 2 | 2009 | 100 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2013 | 1609 | 0.040 |
Why?
|
| Female | 1 | 2017 | 20969 | 0.040 |
Why?
|
| Action Potentials | 2 | 2012 | 231 | 0.040 |
Why?
|
| Models, Biological | 3 | 2009 | 677 | 0.040 |
Why?
|
| Kinetics | 2 | 2009 | 708 | 0.040 |
Why?
|
| Hydrogen | 2 | 1994 | 47 | 0.040 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1996 | 1 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1996 | 9 | 0.040 |
Why?
|
| Ganglia, Invertebrate | 1 | 1996 | 22 | 0.040 |
Why?
|
| Cell Survival | 1 | 2019 | 864 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1996 | 140 | 0.030 |
Why?
|
| Ion Exchange | 1 | 1994 | 1 | 0.030 |
Why?
|
| Enzyme Activation | 2 | 2009 | 444 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 1618 | 0.030 |
Why?
|
| Anions | 1 | 1994 | 39 | 0.030 |
Why?
|
| Calcium | 2 | 2008 | 480 | 0.030 |
Why?
|
| Propionates | 1 | 1994 | 26 | 0.030 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2013 | 2 | 0.030 |
Why?
|
| Halothane | 1 | 2013 | 3 | 0.030 |
Why?
|
| Isoflurane | 1 | 2013 | 3 | 0.030 |
Why?
|
| Volatilization | 1 | 2013 | 23 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2013 | 35 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 56 | 0.030 |
Why?
|
| Mercury | 1 | 2013 | 39 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 60 | 0.030 |
Why?
|
| Cell Fractionation | 2 | 2005 | 30 | 0.030 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 2 | 2005 | 35 | 0.030 |
Why?
|
| Brain | 1 | 2001 | 1346 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 34 | 0.030 |
Why?
|
| Mice | 2 | 2013 | 5913 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 1992 | 58 | 0.030 |
Why?
|
| Zinc | 1 | 2013 | 128 | 0.030 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 77 | 0.030 |
Why?
|
| Protein Transport | 1 | 2011 | 302 | 0.020 |
Why?
|
| Water-Electrolyte Balance | 1 | 2009 | 17 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 803 | 0.020 |
Why?
|
| Marine Toxins | 1 | 2008 | 13 | 0.020 |
Why?
|
| Amiloride | 1 | 2008 | 18 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2008 | 21 | 0.020 |
Why?
|
| Ruthenium | 1 | 2008 | 15 | 0.020 |
Why?
|
| Uridine Triphosphate | 1 | 2008 | 7 | 0.020 |
Why?
|
| Melanosis | 1 | 1988 | 3 | 0.020 |
Why?
|
| Fura-2 | 1 | 2008 | 12 | 0.020 |
Why?
|
| Umbilical Veins | 1 | 2008 | 17 | 0.020 |
Why?
|
| Facial Dermatoses | 1 | 1988 | 10 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2008 | 21 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2008 | 24 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 142 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 181 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2008 | 196 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2008 | 208 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2007 | 223 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 477 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2007 | 223 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2005 | 1 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2005 | 40 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 32 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2005 | 22 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2007 | 343 | 0.020 |
Why?
|
| RNA Interference | 1 | 2007 | 243 | 0.020 |
Why?
|
| Electric Conductivity | 1 | 1985 | 51 | 0.020 |
Why?
|
| Isomerism | 1 | 2005 | 63 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2005 | 70 | 0.020 |
Why?
|
| Muscles | 1 | 1985 | 82 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2005 | 57 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 1985 | 48 | 0.020 |
Why?
|
| Homeostasis | 1 | 2007 | 188 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2005 | 141 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2005 | 201 | 0.020 |
Why?
|
| Diterpenes | 1 | 2005 | 92 | 0.020 |
Why?
|
| DNA Primers | 1 | 2005 | 286 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 218 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 169 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 623 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 269 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 859 | 0.010 |
Why?
|
| Hippocampus | 1 | 2005 | 561 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 587 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 2001 | 47 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2005 | 1207 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2001 | 207 | 0.010 |
Why?
|
| Long-Term Potentiation | 1 | 2001 | 102 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2001 | 161 | 0.010 |
Why?
|
| Caveolin 2 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 130 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 2231 | 0.010 |
Why?
|
| Coated Vesicles | 1 | 1998 | 1 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1992 | 305 | 0.010 |
Why?
|
| Cosmetics | 1 | 1988 | 9 | 0.000 |
Why?
|
| Sunlight | 1 | 1988 | 47 | 0.000 |
Why?
|
| Puerto Rico | 1 | 1988 | 1378 | 0.000 |
Why?
|